D-0065-2021 Class III Terminated
FDA drug recall D-0065-2021 was initiated by Aurobindo Pharma USA Inc. on Oct 22, 2020 and is designated Class III. Reason for recall: Labeling Not Elsewhere Classified: Ibuprofen Oral Suspension is missing dosing cups. The recall status is terminated (terminated Apr 4, 2023). Affected quantity: 7440 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Nov 11, 2020
- Initiation Date
- Oct 22, 2020
- Termination Date
- Apr 4, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 7440 bottles
Product description
Fluent Children's Fever + Pain IBUPROFEN Oral Suspension USP 100 mg per 5 mL Pain Reliever/Fever Reducer, 4 fl oz (120 mL), Berry Flavor, Distributed by Chalkboard Health Inc. Princeton, NJ 08540 getfluenthealth.com Made in India. NDC 79395-003-92
Reason for recall
Labeling Not Elsewhere Classified: Ibuprofen Oral Suspension is missing dosing cups.
Distribution pattern
NJ
Code information
Lot # BO1020080AA3, EXP 7/2023
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0065-2021
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026